- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04677374
Uptake of Medical Male Circumcision Among Men With Sexually Transmitted Infections (VMMC-RITe)
Uptake of Voluntary Medical Male Circumcision Among Men Attending a Sexually Transmitted Infections Clinic in Lilongwe, Malawi
The intervention includes provision of transport reimbursement for men who will undergo voluntary medical male circumcision (VMMC), intensified health education by a VMMC mobilizer and a male and female VMMC champion and use of a cell phone short messaging service (SMS) and/or telephonic tracing to remind clients of their VMMC appointment (the RITe intervention). The investigators will assess the uptake of VMMC, and acceptability, appropriateness and feasibility of the RITe intervention among uncircumcised men attending a Sexually Transmitted Infection (STI) clinic and health care workers.
This intervention was initially designed to include escorting men interested in circumcision from the STI clinic to a VMMC clinic co-located in the same facility. However, the VMMC clinic space was repurposed to a COVID-19 isolation unit therefore clinic escorts were excluded. In Lieu of clinic escorts, participants will be linked to the nearest health facility of choice where VMMC services are provided by the VMMC mobilizer.
The purpose of the study is to evaluate the impact of using transport reimbursement, intensified health education and SMS/telephonic tracing in increasing the uptake of voluntary medical male circumcision at this clinic.
Study Overview
Status
Conditions
Detailed Description
This study will be a pragmatic, pre- and post-interventional quasi-experimental study combined with a prospective observational study design. The study will have pre-implementation and implementation phases and use a concurrent exploratory mixed method approach.
The study will evaluate the effect of multi-faceted intervention on the uptake of VMMC. The intervention includes use of transport reimbursement for men who will undergo VMMC, Intensified health education by VMMC champions and women and use of SMS/telephonic Tracing to remind clients of their VMMC appointment (the RITe intervention).
The intervention will be conducted in a sequential and incremental manner called implementation blocks. After collecting data from the standard of care period, the first implementation block will be for intensified health education. The next block will combine intensified health education with SMS/telephonic tracing. The last block will combine intensified health education with SMS/telephonic tracing and transport reimbursements. This approach will allow the investigator to compare the effectiveness of different combinations of the strategies in the intervention without necessarily randomizing participants. The sample size for each block is expected to be at least 80 uncircumcised men with STIs. The investigators anticipate that each block may last about 4-12 weeks (to allow the interventions to mature) with one week of no intervention between interventions as a wash out period. However, sample size may be higher if more uncircumcised men present within the minimum 4-week intervention period.
The study population will be men attending the Bwaila STI clinic in Lilongwe Malawi. The study will enroll a minimum of 320 men to depict an uptake rate of circumcision of about 28% (national average including traditional circumcision) among uncircumcised men. However, for each intervention to settle, the investigator will implement each intervention for at least 4 weeks.
Data on uptake of VMMC will be collected through a standardize data collection form in conjunction with routine data from the STI clinic electronic medical registry. Data on acceptability, appropriateness and feasibility will be collected through surveys, interviews and focus group discussions. The investigators will conduct about 280 surveys for acceptability, appropriateness and feasibility with men selected randomly through the implementation period (70 men per intervention block). About 20 in-depth interviews with healthcare workers equally divided by intervention block will be conducted to assess acceptability, appropriateness and feasibility. Finally, the investigators will conduct four focus group discussions with men through the study period to assess acceptability, appropriateness and feasibility of the RITe strategy.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Lilongwe, Malawi
- UNC Project-Malawi (Bwaila District Hospital)
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Male
- 18 years or older
- Seeking STI care at the Bwaila STI clinic
- Not circumcised
- Healthcare workers at Bwaila STI and VMMC clinic
Exclusion Criteria:
- < 18 years of age
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Non-Randomized
- Interventional Model: Sequential Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Placebo Comparator: Standard of care
Participants in this arm will be offered Standard of Care (SOC) referral process for voluntary medical male circumcision (VMMC) services
|
Standard of care referral approach which is a brief health talk conducted once every morning by a VMMC mobilizer.
|
Experimental: Block 1 (intensified health education)
Participants in this arm will be offered intensified health education
|
More detailed health talk conducted during each group health talk session by the VMMC mobilizer and champions describing VMMC, its benefits and how to access the service and testimonies from men who have successfully undergone VMMC
|
Experimental: Block 2 (intensified health education and SMS/telephonic tracing)
Participants in this arm will be offered intensified health education and SMS/telephonic tracing
|
SMS tracing to remind participants of VMMC appointments
|
Experimental: Block 3 (intensified health education, SMS/telephonic tracing and transport reimbursement)
Participants in this arm will be offered intensified health education, SMS/telephonic tracing and transport reimbursement
|
Transportation reimbursement to offset the cost of transportation for VMMC appointments
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of Male Clients Who Will Undergo Circumcision (Uptake of VMMC)
Time Frame: up to 30 days
|
Each participant will be followed for 30 days to determine whether or not they receive circumcision.
Number of participants who will undergo circumcision will be reported.
The investigators will collect data on the number of participants offered VMMC and the number of participants who will undergo VMMC for each intervention block.
|
up to 30 days
|
Median Number of Days Taken for Male Clients to Undergo Circumcision From the Day Offered Circumcision at the STI Clinic (Time-to-circumcision)
Time Frame: up to 30 days
|
The duration in days from when participants are offered VMMC to when the participants will undergo VMMC.
The investigators will collect data on the number of days taken from the day circumcision is offered for each participant to undergo VMMC through the 30-day Follow-Up period.
|
up to 30 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Percentage of Male Clients Who Reported the RITe Intervention As Acceptable
Time Frame: Baseline and Follow-Up, up to 30 days
|
Acceptability measured quantitatively using the Acceptability of Intervention Measure (AIM) Likert scale surveys.
The AIM Likert scale measures acceptability based on four constructs that assess whether an intervention is appealing, likable, welcome and approvable.
The AIM score ranges from 6 - 80 1=completely disagree, 2=disagree, 3=Neutral, 4=agree and 5=completely agree.
Higher scores indicate agreement with more acceptability items.
The percentage is reported for those who strongly agree or agree assessed at Baseline and Follow-Up.
|
Baseline and Follow-Up, up to 30 days
|
Number of Male Clients With Perception That the RITe Intervention is Acceptable
Time Frame: Baseline, End of Study Follow Up (approximately Week 82)
|
Qualitative assessments for acceptability conducted using focus group discussions with uncircumcised men.
Focus group discussions were conducted at Baseline and End of Study Follow Up to complement quantitative findings.
Focus group discussions analyzed using thematic analysis and a summary of common themes presented.
|
Baseline, End of Study Follow Up (approximately Week 82)
|
Percentage of Healthcare Workers Who Rated the RITe Intervention as Feasible
Time Frame: End of Study Follow Up (approximately Week 82)
|
Feasibility measured quantitatively using the Feasibility of Intervention Measure (FIM) Likert scale surveys.
The FIM measures feasibility based on four constructs that assess whether an intervention is implementable, possible, resources, and difficult to use.
Feasibility assessed among Healthcare Workers only as implementers of the intervention.
Surveys for feasibility will be conducted for each intervention block during the implementation phase only.
The FIM score range is 5 - 60 with 1=completely disagree, 2=disagree, 3=Neutral, 4=agree and 5=completely agree.
Higher scores indicate agreement with more feasibility items.
The percentage is reported for those who strongly agree or agree assessed at End of Study Follow Up.
|
End of Study Follow Up (approximately Week 82)
|
Number of Healthcare Workers With Perception That the RITe Intervention is Feasible
Time Frame: End of Study Follow Up (approximately Week 82)
|
Qualitative assessments for intervention feasibility conducted using in-depth interviews with Healthcare Workers only at End of Study Follow Up to complement quantitative findings.
The interviews were analyzed using thematic analysis and a summary of common themes presented.
|
End of Study Follow Up (approximately Week 82)
|
Number of Healthcare Workers With Perception That the RITe Intervention is Acceptable at Baseline
Time Frame: Baseline
|
Qualitative assessments for acceptability conducted using in-depth interviews with Healthcare Workers at Baseline for the Standard of Care arm to complement quantitative findings.
In-depth interviews were analyzed using thematic analysis and a summary of common themes presented.
|
Baseline
|
Number of Healthcare Workers With Perception That the RITe Intervention is Acceptable at End of Study Follow Up
Time Frame: End of Study Follow Up (approximately Week 82)
|
Qualitative assessments for acceptability conducted using in-depth interviews with Healthcare Workers at End of Study Follow Up for the Block 3 arm to complement quantitative findings.
In-depth interviews were analyzed using thematic analysis and a summary of common themes presented.
|
End of Study Follow Up (approximately Week 82)
|
Percentage of Male Clients Who Reported the RITe Intervention As Appropriate
Time Frame: Baseline and Follow-Up, up to 30 days
|
Appropriateness measured quantitatively using the Intervention Appropriateness Measure (IAM) Likert scale surveys.
The IAM Likert scale measures appropriateness based on four constructs that assess whether an intervention is embarrassing, culturally & religiously suitable, and a good idea.
Surveys for appropriateness were conducted at baseline and during implementation of each intervention block.
The IAM score range is 5 - 85 from a scale with 1=completely disagree, 2=disagree, 3=Neutral, 4=agree and 5=completely agree.
Higher scores indicate agreement with more appropriateness items.
The percentage is reported for those who strongly agree or agree assessed at Baseline and Follow-Up.
|
Baseline and Follow-Up, up to 30 days
|
Number of Male Clients With Perception That the RITe Intervention is Appropriate
Time Frame: Baseline, End of Study Follow Up (approximately Week 82)
|
Qualitative assessments for appropriateness conducted using focus group discussions with uncircumcised men.
Focus group discussions conducted at Baseline and End of Study Follow Up to complement quantitative findings.
Focus group discussions were analyzed using thematic analysis and a summary of common themes presented.
|
Baseline, End of Study Follow Up (approximately Week 82)
|
Number of Healthcare Workers With Perception That the RITe Intervention is Appropriate at Baseline
Time Frame: Baseline
|
Qualitative assessments for appropriateness conducted using in-depth interviews with Healthcare Workers only.
The interviews were conducted at Baseline to complement quantitative findings.
The Interviews were analyzed using thematic analysis and a summary of common themes presented.
|
Baseline
|
Number of Healthcare Workers With Perception That the RITe Intervention is Appropriate at End of Study Follow Up
Time Frame: End of Study Follow Up (approximately Week 82)
|
Qualitative assessments for appropriateness conducted using in-depth interviews with Healthcare Workers only.
The interviews were conducted at End of Study Follow Up to complement quantitative findings.
The Interviews were analyzed using thematic analysis and a summary of common themes presented.
|
End of Study Follow Up (approximately Week 82)
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Mitch Matoga, MD, MSc, UNC
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 19-2559
- D43TW010060 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on HIV Infections
-
University of MinnesotaWithdrawnHIV Infections | HIV/AIDS | Hiv | AIDS | Aids/Hiv Problem | AIDS and InfectionsUnited States
-
University of California, San DiegoUniversity of California, Los Angeles; University of Southern California; California... and other collaboratorsCompleted
-
Gérond'ifRecruiting
-
University of California, DavisCompleted
-
University of California, San DiegoNational Center for Complementary and Integrative Health (NCCIH)CompletedHIV PositiveUnited States
-
University of ChicagoUniversity of Athens; National Development and Research Institutes, Inc.Completed
-
HIV Prevention Trials NetworkNational Institute on Drug Abuse (NIDA); National Institute of Allergy and...CompletedHIV PositiveIndonesia, Ukraine, Vietnam
-
University of ZimbabweCompleted
-
Florida International UniversityCompleted
-
Boston Children's HospitalNational Institute on Minority Health and Health Disparities (NIMHD)Completed
Clinical Trials on Standard of care
-
Johns Hopkins UniversityRecruitingCompartment Syndrome of Leg | Extracorporeal Membrane Oxygenation Complication | Limb Ischemia, Critical | Limb IschemiaUnited States
-
brett rasmussenCompleted
-
Indonesia UniversityCompletedCovid19 | AcupunctureIndonesia
-
Aventusoft, LLC.National Heart, Lung, and Blood Institute (NHLBI); Cleveland Clinic FloridaRecruitingHeart Failure (HF)United States
-
Vascular Biogenics Ltd. operating as VBL TherapeuticsCompletedSevere COVID-19Israel
-
Ruijin HospitalRecruitingCOVID-19 PneumoniaChina
-
Institut Claudius RegaudCompletedMETASTATIC CANCERFrance
-
Ziv HospitalNot yet recruiting
-
Hofseth Biocare ASAKGK Science Inc.CompletedCovid-19 | COVIDCanada, Brazil, Hungary, Mexico, Serbia
-
City University of New York, School of Public HealthNew York State Psychiatric Institute; University of KwaZulu; International Initiative... and other collaboratorsCompleted